Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency.
Van Norman
G A
GA
Department of Anesthesiology, University of Washington, Seattle 98195, USA.
Gernsheimer
T
T
Chandler
W L
WL
Cochran
R P
RP
Spiess
B D
BD
D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D002315:Cardiopulmonary Bypass; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood
D017395:Plasminogen Activator Inhibitor 1; D000990:Antithrombin III